British Journal of Urology · 2005 · 16 citations · 24 references
MedicineOncologyUrologyMetastasisMolecular OncologyTumor ProgressionAngiogenesisAngiogenesis In CancerCancer ProgressionMalignant NeoplasmsMetastatic DisseminationProstate CancerAngiogenesis In NeoplasmsAngiogenic BiomarkersCancer Metastasis BiomarkersCorrelationCyclooxygenase-2 PathwayMetastasis Of Prostate CancerMetastatic BiomarkersMetastatic Prostatic Carcinoma
OBJECTIVE: To test the hypothesis that angiogenesis in prostate cancer is associated with tumour invasion and metastasis, and that this is mediated through increased cyclooxygenase-2 (COX-2) expression. PATIENTS AND METHODS: Angiogenesis was assessed in 105 patients with either prostate cancer (79) or benign prostatic hyperplasia (BPH, 26) and these data correlated with levels of COX-2 expression in the same dataset. The mean microvessel density (MVD) was analysed as a marker of angiogenesis, using the endothelial antigen CD34 stained by immunohistochemistry. RESULTS: There was no difference in MVD in progressive tumour stages compared with BPH. There was a negative correlation between MVD and COX-2 expression, but the effect of increased COX-2 expression on MVD was not marked. CONCLUSION: These data suggest that COX-2 drives tumour spread in prostate cancer by means other than the promotion of angiogenesis.
24
Expression of cyclooxygenase-1 and -2 in human colorectal cancer.
Hajime Sano, Yutaka Kawahito, Ronald L. Wilder et al. · PubMed · 1995 · 1.1K citations
Medicine, Oncology, Pharmacology +10
Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma
Sanjay Gupta, Mayank Srivastava, Nihal Ahmad et al. · The Prostate · 2000 · 531 citations
Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity
Michael K. Brawer, Robert E. Deering, Marianne Brown et al. · Cancer · 1994 · 410 citations